Lenvakast 4mg (Lenvatinib)

Lenvakast 4 mg

Composition: Lenvatinib 10mg

Classification: Anticancer Medicine

What is Lenvakast?

It is an anticancer medicine used to treat advanced cancer and refractory cancers.

Uses of Lenvakast

Radioactive -Iodine refractory differentiated thyroid cancer

Renal carcinoma

Endometrial cancer

Unresectable liver cancer

How does Lenvakast work?

It is a multiple tyrosine kinase inhibitor

Targets the blood supply to the cancer cells

Cause cancer cell starvation

Cancer cell death

Common side effects include

High BP

Tiredness

Diarrhea

Nausea

Loss of appetite

Weight decline

Hand and foot syndrome

Pain in muscles and joints

Serious Side-effects

Hypertensive crisis - severely high BP

Thrombosis -strokes, heart attack

Kidney dysfunction -proteinuria

Cardiovascular - shortness of breath,

Bleeding in the stomach

Increased liver enzymes

Thyroid dysfunction

Delayed wound healing

Neurotoxicity - confusion, headache, vision loss

Precautions -

To be cautiously used in patients with -

History of stroke, heart disease

Liver disorders

Kidney disorders

Elderly patients

Planning a surgery

Contraindication -

Not to be used if any previous allergy or hypersensitivity to lenvatinib or any excipients.

Breastfeeding mothers

Pregnant women

Warning

To be used under medical prescription only

Important Safety and Monitoring Information

Regularly monitor -

Liver function,

Blood pressure,

Thyroid functions,

Neurological condition

Renal function.